ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

SNSE Sensei Biotherapeutics Inc

1,81
0,00 (0,00%)
Zuletzt aktualisiert: 15:42:15
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Sensei Biotherapeutics Inc SNSE NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 1,81 15:42:15
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,80 1,7739 1,85 1,81
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
05.3.202422:44EDGAR2Form 8-K - Current report
28.2.202413:31EDGAR2Form 8-K - Current report
17.2.202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.2.202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.2.202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202422:31EDGAR2Form 8-K - Current report
04.1.202414:14EDGAR2Form 8-K - Current report
07.11.202322:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202313:35EDGAR2Form 8-K - Current report
07.11.202313:30GLOBESensei Biotherapeutics Reports Third Quarter 2023 Financial..
06.11.202312:07EDGAR2Form 8-K - Current report
03.11.202321:11EDGAR2Form 8-K - Current report
03.11.202321:05GLOBESensei Biotherapeutics Reports Favorable Clinical Data for..
02.11.202321:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.11.202321:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
01.11.202312:30GLOBESensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as..
25.10.202315:05GLOBESensei Biotherapeutics to Present Initial Clinical Data from..
23.10.202313:30GLOBESensei Biotherapeutics Presents Trial-in-Progress Poster for..
20.10.202323:01EDGAR2Form 8-K - Current report
27.9.202313:30GLOBESensei Biotherapeutics Announces Initiation of Combination..
21.9.202313:30GLOBESensei Biotherapeutics Presents New Preclinical Data..
13.9.202314:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.9.202313:30GLOBESensei Biotherapeutics to Present New Preclinical Data..
11.9.202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.9.202323:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.9.202323:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.9.202323:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.8.202313:30GLOBESensei Biotherapeutics to Participate in Upcoming Investor..
17.8.202323:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03.8.202322:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202314:45EDGAR2Form 8-K - Current report
03.8.202313:30GLOBESensei Biotherapeutics Reports Second Quarter 2023 Financial..
02.8.202323:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.8.202313:30GLOBESensei Biotherapeutics to Participate in Canaccord Genuity’s..
12.7.202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.7.202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.7.202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.7.202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.7.202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.7.202322:31EDGAR2Form 8-K - Current report
01.6.202313:30GLOBESensei Biotherapeutics Announces First Patient Dosed in..
09.5.202313:30GLOBESensei Biotherapeutics Reports First Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock